DNA repair and tumour radiosensitivity: Focus on ATM gene;Réparation cellulaire et radiosensibilité tumorale: Focus sur le gène ATM

Bulletin du Cancer

Volumn 98, Issue 3, 2011, Pages 239-246

  Hennequin, Christophe ^a,b   Quero, Laurent ^a,b   Favaudon, Vincent ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b INSERM U612   (France)

Author keywords

ATM; DNA repair; p53; Radiosensitivity

Indexed keywords

ATM PROTEIN; PROTEIN P53;

APOPTOSIS; CANCER GROWTH; CANCER RADIOTHERAPY; CELL CYCLE ARREST; CLONOGENESIS; DNA DAMAGE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; GENE MUTATION; HUMAN; HYPOXIA; IMMUNOCHEMISTRY; IONIZING RADIATION; RADIOSENSITIVITY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

EID: 79955098395     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2011.1324     Document Type: Review

References (47)

1. Garcia-Barros M, Paris F, Cordon-Cardo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003 : 300.
2. Baumann M, duBois W, Suit H. Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units. Radiat Res 1990 ; 123 : 325-30. (Pubitemid 20327905)
3. Fertil B, Malaise E. Intrinsic radiosensitivity of human cells is correlated with radioresponsiveness of human tumors. Int J Radiat Oncol Biol Phys 1985 ; 11 : 1699-707. (Pubitemid 15233633)
4. Weichselbaum RR, Beckett MA, Schwartz JL, et al. Radio-resistant tumor cells are present in head and neck carcinomas that reccur after radiotherapy. Int J Radiat Oncol Biol 1988 ; 15 : 575-9.
5. West CM, Davidson SE, Hunter RD. Evaluation of surviving fraction at 2 Gy as a potential prognostic factor for the radiotherapy of carcinoma of the cervix. Int J Radiat Biol 1989 ; 56 : 761-5. (Pubitemid 20002025)
6. Bjork-Eriksson T, West C, Karlsson E, et al. Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers. Int J Radiat Oncol Biol Phys 2000 ; 46 : 13-9. (Pubitemid 30021473)
7. Iliakis G. The role of DNA double-strand breaks in ionizing radiation-induced killing of eukaryotics cells. Bioessays 1991 ; 13 : 641-8. (Pubitemid 21892586)
8. Favaudon V. Effets cellulaires des rayonnements ionisants. Radiosensibilité, cycle cellulaire et mort cellulaire. In : Tubiana M, editor. Radiobiologie. Paris : Hermann, 2007.
9. Joubert A, Foray N. Radiosensibilité intrinsèque et cassures double-brin de l'ADN dans les cellules humaines. Cancer Radioth 2007 ; 11 : 129-42.
10. Valerie K, Povirk L. Regulation and mechanisms of mammalian double-strand break reapir. Oncogene 2003 ; 22 : 5792-812. (Pubitemid 37176701)
11. Iliakis G,Wang H, Perrault AR, et al. Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenet Genome Res 2004 ; 104 : 14-20. (Pubitemid 38721048)
12. Savitsky K, Bar-Shira A, Gilad S, et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995 ; 268 : 1749-53.
13. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003 ; 421 : 499-506. (Pubitemid 36168436)
14. Riballo E, Kuhne M, Rief N, et al. A pathway of double-strand break rejoining dependent upon ATM. Artemis, and proteins locating to gamma-H2AX foci. Mol Cell 2004 ; 16 : 715-24. (Pubitemid 39586530)
15. Mahaney BL, Meek K, Lees-Miller SP. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J 2009 ; 417 : 639-50.
16. Fernandez-Capetillo O, Celeste A, Nussenzweig A. Focusing on foci: H2AX and the recruitment of DNA-damage response factors. Cell Cycle 2003 ; 2 : 426-7.
17. Celeste A, Difilippantonio S, Difilippantonio MJ, et al. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 2003 ; 114 : 371-83. (Pubitemid 36962935)
18. Stucki M, Clapperton JA, Mohammad D, et al. MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 2005 ; 123 : 1213-26. (Pubitemid 41821780)
19. Chapman JR, Jackson SP. Phospho-dependent interactions between NBS1 and MDC1 mediate chromatin retention of the MRN complex at sites of DNA damage. EMBO Rep 2008 ; 9 : 795-801.
20. Olive PL, Banath JP. Phosphorylation of histone H2AX as a measure of radiosensitivity. Int J Radiat Oncol Biol Phys 2004 ; 58 : 331-5. (Pubitemid 38142456)
21. Banath JP, Macphail SH, Olive PL. Radiation sensitivity. H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res 2004 ; 64 : 7144-9. (Pubitemid 39331029)
22. Taneja N, Davis M, Choy JS, et al. Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem 2004 ; 279 : 2273-80. (Pubitemid 38084500)
23. Stewart GS. Solving the RIDDLE of 53BP1 recruitment to sites of damage. Cell Cycle 2009 ; 8 : 1532-8.
24. Taylor AM, Harnden DG, Arlett CF, et al. Ataxia telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 1975 ; 258 : 427-9.
25. Chun HH, Gatti RA. Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst) 2004 ; 3 : 1187-96. (Pubitemid 38997962)
26. Hennequin C, Giocanti N, Averbeck D, et al. La DNA-PK : une enzyme-clé de la réparation des lésions radio-induites. Cancer/ Radioth 1999 ; 3 : 289-95.
27. Metcalfe JA, Parkhill J, Campbell L, et al. Accelerated telomere shortening in ataxia telangiectasia. Nat Genet 1996 ; 13 : 350-3. (Pubitemid 26230503)
28. Gutierrez-Enriquez S, Fernet M, Dork T, et al. Functional consequences of ATM sequence variants for chromosomal radiosensitivity. Genes Chromosomes Cancer 2004 ; 40 : 109-19. (Pubitemid 38579879)
29. West CM, Elyan SA, Berry P, et al. A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (AT) and AT heterozygotes. Int J Radiat Biol 1995 ; 68 : 197-203.
30. Chan DW, Gately DP, Urban S, et al. Lack of correlation between ATM protein expression and tumour cell radiosensitivity. Int J Radiat Biol 1998 ; 74 : 217-24. (Pubitemid 28372548)
31. Tribius S, Pidel A, Casper D. ATM protein expression correlates with radioresistance in primary glioblastoma cells in culture. Int J Radiat Oncol Biol Phys 2001 ; 50 : 511-23. (Pubitemid 32472281)
32. Angele S, Romestaing P, Moullan N, et al. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. Cancer Res 2003 ; 63 : 8717-25. (Pubitemid 38064049)
33. Dombernowsky SL, Weischer M, Allin KH, et al. Risk of cancer by ATM missense mutations in the general population. J Clin Oncol 2008 ; 26 : 3057-62.
34. Hall J. The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants. Cancer Lett 2005 ; 227 : 105-14. (Pubitemid 41169924)
35. Andreassen CN, Alsner J, Overgaard J, et al. TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. Radiother Oncol 2005 ; 75 : 18-21. (Pubitemid 40616789)
36. De Ruyck K, Van Eijkeren M, Claes K, et al. TGFbeta1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors. Int J Radiat Oncol Biol Phys 2006 ; 65 : 1240-8.
37. Chargari C, Kirova YM, Even C, et al. Adjuvant irradiation in breast cancer patients with ATM gene heterozygous mutations: special focus on clinical efficacy/toxicity. Cancer Radiother 2009 ; 13 : 164-72.
38. Ho AY, Fan G, Atencio DP, et al. Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2007 ; 69 : 677-84. (Pubitemid 47418400)
39. Azria D, Ozsahin M, Kramar A, et al. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res 2008 ; 14 : 6284-8.
40. Fernet M, Hall J. Genetic biomarkers of therapeutic radiation sensitivity. DNA Repair (Amst) 2004 ; 3 : 1237-43. (Pubitemid 38997967)
41. Meyer A, John E, Dork T, et al. Breast cancer in female carriers of ATM gene alterations: outcome of adjuvant radiotherapy. Radiother Oncol 2004 ; 72 : 319-23. (Pubitemid 39265386)
42. Su Y, Swift M. Outcomes of adjuvant radiation therapy for breast cancer in women with ataxia-telangiectasia mutations. JAMA 2001 ; 286 : 2233-4. (Pubitemid 33063141)
43. Soderlund K, Stal O, Skoog L, et al. Intact Mre11/Rad50/Nbs1 complex predicts good response to radiotherapy in early breast cancer. Int J Radiat Oncol Biol Phys 2007 ; 68 : 50-8. (Pubitemid 46589837)
44. Komuro Y,Watanabe T, Hosoi Y, et al. The expression pattern of Ku correlates with tumor radiosensitivity and disease free survival in patients with rectal carcinoma. Cancer 2002 ; 95 : 1199-205. (Pubitemid 35013052)
45. Wilson CR, Davidson SE, Margison GP, et al. Expression of Ku70 correlates with survival in carcinoma of the cervix. Br J Cancer 2000 ; 83 : 1702-6. (Pubitemid 32001717)
46. Bjork-Eriksson T, West C, Nilsson A, et al. The immunohistochemical expression of DNA-PKCS and Ku (p70/p80) in head and neck cancers: relationships with radiosensitivity. Int J Radiat Oncol Biol Phys 1999 ; 45 : 1005-10. (Pubitemid 29525466)
47. Allalunis-Turner MJ, Lintott LG, Barron GM, et al. Lack of correlation between DNA-dependent protein kinase activity and tumor cell radiosensitivity. Cancer Res 1995 ; 55 : 5200-2.